DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis

CONCLUSION: Our findings provide new insights about DWN12088, namely that it plays an important role in the overall improvement of NASH. Hence, DWN12088 shows great potential to be developed as a new integrated therapeutic agent for NASH.PMID:38173372 | DOI:10.4093/dmj.2022.0367

Source: Diabetes and Metabolism Journal - January 4, 2024 Category: Endocrinology Authors: Dong-Keon Lee Su Ho Jo Eun Soo Lee Kyung Bong Ha Na Won Park Deok-Hoon Kong Sang-In Park Joon Seok Park Choon Hee Chung Source Type: research